CADTH Communiqué — Volume 1, No. 2
Reports Released
A supplemental report to Polymerase Chain Reaction Tests for Methicillin-Resistant Staphylococcus aureus in Hospitalized Patients: Clinical and Cost-Effectiveness Analyses has now been released.
A technology report entitled Clopidogrel versus Other Antiplatelet Agents for Secondary Prevention of Vascular Events in Adults with Acute Coronary Syndrome or Peripheral Vascular Disease: Clinical and Cost-Effectiveness Analyses has now been released.
Therapeutic Review
A revised version of the CADTH report Therapeutic Review Clinical and Economic Overview: Biological Response Modifier Agents for Adults with Rheumatoid Arthritis is now available.
Event
If you are in the Toronto area, don’t miss our Café Scientifique that will encourage discussion about self-monitoring of blood glucose in patients with type 2 diabetes not using insulin.
Job Posting
CADTH is seeking candidates for the Director, Common Drug Review (CDR) and Rapid Response Service position.